MENU

PLX Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys PLX on September 02, 2025, netting in a 23.23% gain over 2 weeks

A.I.dvisor
at Tickeron.com
Loading...
+23.23% Gain from a Successful pattern Three Rising Valleys
PLX - Protalix BioTherapeutics
Tickeron
Ticker: PLX
Company: Protalix BioTherapeutics
Gain: +23.23%
Confirmed: 09/02/25
Succeeded: 09/15/25
Total length: 18 days
On August 28, 2025, A.I.dvisor detected a Three Rising Valleys Pattern (Bullish) for Protalix BioTherapeutics (PLX, $1.55). On September 02, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $1.90. 13 days later, on September 15, 2025, PLX reached the target price resulting in a +2 for traders who took a long position in the stock.

PLX in +9.68% Uptrend, rising for three consecutive days on September 22, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PLX advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 09, 2025. You may want to consider a long position or call options on PLX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PLX just turned positive on September 09, 2025. Looking at past instances where PLX's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 183 cases where PLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLX broke above its upper Bollinger Band on September 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.259) is normal, around the industry mean (19.844). P/E Ratio (22.667) is within average values for comparable stocks, (54.097). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.112). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (2.743) is also within normal values, averaging (344.917).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PLX showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com